Effect of Strontium-89 on painful bone metastases in zoledronic acid received patients with prostate cancer
Phase 2
- Conditions
- Prostate Cancer
- Registration Number
- JPRN-UMIN000004718
- Lead Sponsor
- Keio University Shool of Medicine Department of Urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with severe renal failure 2. Patients with ongoing chemotherapy 3. Patients with ongoing external radiotherapy 4. Patients with unmanageable urinary incontinence 5. Patients with severe complication 6. Patients with history of drug allergy that are considered inappropriate to conduct this trial 7. Other patients deemed not appropriate for study entry by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate (the ratio of responder to bone pain)
- Secondary Outcome Measures
Name Time Method Safety and mechanism(changes in the level of tumor marker and bone turnover marker)